Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress

8th October 2008 SAN DIEGO, October 8 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine (Poly-ICR), at the World Vaccine Congress 2008 in Lyon, France. Study results demonstrated Poly-ICR to be a potent vaccine adjuvant targeting the Toll-like Receptor 3 (TLR3) pathway. Data showed that Poly-ICR, in combination with model antigens, elicits strong anti-target antibody... more

Informex to Hold Global Sourcing Strategies Conference for the Pharmaceutical Industry

7th October 2008 PRINCETON, New Jersey, October 7 /PRNewswire/ -- Informex today announced that it will hold a Global Sourcing Summit for the Pharmaceutical Industry, November 10-11, at Princeton, New Jersey, USA. The two-day conference will address the next generation of operational and business strategies in the field of global pharmaceutical procurement. David Kinnear, President & CEO of the Global Sourcing Council, will chair the inaugural conference and host a panel of distinguished speakers with... more

CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure

7th October 2008 ATLANTA, October 7 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that cardiovascular surgeons from around the globe will participate in the Ross Summit 2008, a two-day surgical congress to be held at the Company's corporate headquarters training facility in Kennesaw, Ga. The program, slated for Oct. 10 and 11, has piqued the interest of the worldwide cardiovascular surgical community with approximately 80 cardiovascular... more
Trade Shows RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent news

CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
7th October 2008 WASHINGTON, October 7 /PRNewswire/ -- CeloNova BioSciences, Inc. today announced that it will showcase the technology behind the CATANIA(TM) Coronary Stent System featuring a NanoThin Polyzene(R)-F...

Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
6th October 2008 LONDON, October 6 /PRNewswire/ -- The organizers of Informex are delighted to announce their inaugural conference on Global Sourcing for the Pharmaceutical Industry, taking place November 10th-11th...

Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008
6th October 2008 HONG KONG, October 6 /PRNewswire/ -- Data from multiple clinical trials of the world's first pro-healing stent, OrbusNeich's Genous Bio-engineered R stent, will be presented next week at the...

Ageing Populations Face Crisis of Rising Blindness
4th October 2008 LONDON, October 4 /PRNewswire/ -- The world's populations are ageing rapidly, bringing greater risk of blindness and vision impairment to millions. Around the world, organisations of many kinds are...

Simbionix Launches Innovative Patient-Specific Simulation
3rd October 2008 CLEVELAND, Ohio, October 3 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, advances procedural simulation from theoretical promise to operating room reality. ...

Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During 'Live' Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
1st October 2008 PARIS, October 1 /PRNewswire/ -- CeloNova BioSciences, Inc., today announced that Masahiko Ochiai MD, Associate Professor, Division of Cardiology, Yokohama Hospital, Kanagawa, Japan has selected the...

PharmaSRM 2008 - Supplier Relationship Management in the Pharmaceutical Industry - 27th-28th October, Frankfurt, Germany
29th September 2008 FRANKFURT, Germany, September 29 /PRNewswire/ -- With continued pressure on pharma companies to reduce their cost base, procurement departments are seeking innovative ways of managing their...

InNexus Biotechnology CEO to Present at BioContactQuebec 2008
29th September 2008 BRITISH COLUMBIA, Canada, September 29 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the...

Rosetta Genomics to Present at Maxim Group Growth Conference
24th September 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, September 24 /PRNewswire/ -- Rosetta Genomics Ltd (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics, announced today its...

Merck Serono Announces One-Month Results of Pharmacogenomics Study PREDICT at 47th Annual Meeting of the European Society for Paediatric Endocrinology
23rd September 2008 GENEVA, Switzerland, September 23 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today presented the results of the PREDICT study at the 47th Annual Meeting of the...

The 22nd Annual European Association of Hospital Managers Congress to Highlight Leadership in Health Care
23rd September 2008 VIENNA, Austria, September 23 /PRNewswire/ -- More than 600 top hospital administrators from throughout Europe will convene in Graz, Austria on September 25 and 26 for the European Association of...

Health & Natural Ingredients European Conferences 2008 Tuesday 4th - Thursday 6th November, Paris, France
19th September 2008 LONDON, September 19 /PRNewswire/ -- Health and Natural Ingredients alternate annual event has returned with a vibrant, innovative programme which aims to tackle to latest technical, legal and market...

Innovations in Naturals 2008 Conference
19th September 2008 LONDON, September 19 /PRNewswire/ -- Following recent market research, Innovations in Naturals 2008 has been developed to tackle the key technical challenges of moving towards the use of natural...

Inno-Tech Show 2008 will be held in Seoul
18th September 2008 SEOUL, South Korea, September 18 /PRNewswire/ -- A fair featuring innovative technologies developed by Korean small and medium business will be held in Seoul.

New Xcelohood(TM) Containment Hood for Safer Micro-Filling of Potent Compounds
17th September 2008 CAMBRIDGE, England, September 17 /PRNewswire/ -- Capsugel, the world's leading provider of oral dosage form solutions to the pharmaceutical and related healthcare industries, is pleased to...

Palonosetron: The Long-Lasting Antiemetic Action Finds its Basis
12th September 2008 STOCKHOLM, Sweden, September 12 /PRNewswire/ -- New data presented today at the 33rd ESMO (European Society of Medical Oncology) Congress in Stockholm may contribute to explain the reason...

Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer
12th September 2008 BASEL, Switzerland, September 12 /PRNewswire/ -- Avastin's (bevacizumab) essential role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common...

The Challenges Facing Health Europe
11th September 2008 LA SORBONNE, France, September 11 /PRNewswire/ -- On the occasion of the one-day conference organised by Medical Enterprises (Les Entreprises du M

Roche to Present Data Showing Progress in Treating Lung, Gastric and Brain Cancers at ESMO
10th September 2008 BASEL, Switzerland, September 10 /PRNewswire/ -- More than 100 Roche abstracts have been accepted for the biggest cancer congress in Europe, the European Society for Medical Oncology (ESMO),...

Nucletron Announces Advances in Image-Guided Adaptive Brachytherapy Technology for Gynecologic Cancers Through Partnership With AKH / MUW Vienna
9th September 2008 VEENENDAAL, Netherlands, September 9 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, and the world-class medical institution General Hospital Vienna (AKH) /...

Security Software is First to Tackle Disquieting Problem of Insider Threats
8th September 2008 SAN DIEGO, September 8 /PRNewswire/ -- A British developed revolutionary, system-level computer security program Lanxoma (www.lanxoma.com) launched at the prestigious DEMOfall 08...

New Advance Findings Show How to Combine Intensive Blood Glucose and Blood Pressure Lowering for Further Benefits in Type 2 Diabetes
8th September 2008 ROME, September 8 /PRNewswire/ -- According to new data presented today at the European Association for the Study of Diabetes (EASD) congress, combining intensive blood sugar control based on...

InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
8th September 2008 BRITISH COLUMBIA, Canada, September 8 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the...

Get Answers to the Burning Questions About Women's Health
8th September 2008 LONDON, September 8 /PRNewswire/ -- Vagisil(R) are delighted to invite you to The WoW Show - a one-day event, run by Wellbeing of Women, focusing on women's gynaecological health issues at the Royal...

Antibiotics Over-Prescribed Despite Resistance Fears
8th September 2008 LONDON, September 8 /PRNewswire/ -- Antibiotics are still being over-prescribed by GPs in contravention of guidelines, potentially contributing to antibiotic-resistant "superbugs", research launched...

50% of People Ignorant Over Causes of Heart Disease
8th September 2008 LONDON, September 8 /PRNewswire/ -- Over half the public are still ignorant about coronary heart disease (CHD) - the UK's leading killer disease, research launched at the British Pharmaceutical...

Dangerous Side-Effects of Epilepsy Drugs Reduced in New Research
8th September 2008 LONDON, September 8 /PRNewswire/ -- A breakthrough method has been found to reduce the dangerous side-effects of a medicine that successfully tackles epilepsy, according to research released at the...

ME Sufferers Rely on Alternative Medicines
8th September 2008 LONDON, September 8 /PRNewswire/ -- More than a third of patients with long-term fatigue conditions like Myalgic Encephalomyelitis (ME) believe complementary and alternative medicines (CAMs) are more...

Researchers Use Light in MRSA Fight
8th September 2008 LONDON, September 8 /PRNewswire/ -- New treatment using a light-activated drug could revolutionise the fight against hospital "superbug", MRSA (otherwise known as meticillin resistant staphylococcus...

Shedding Light on Bowel Cancer
8th September 2008 LONDON, September 8 /PRNewswire/ -- An effective new method of diagnosing bowel (also known as colorectal, or large bowel) cancer using 'light' may soon be available, according to research presented...

20 Per Cent of GP Cases Could be Handled by Pharmacists
8th September 2008 LONDON, September 8 /PRNewswire/ -- Pharmacists could help reduce GP workloads by 20 per cent, saving the NHS millions of pounds every year, according to Steve Churton, President of the Royal...

Patients at Risk From Hospital Tubes
7th September 2008 LONDON, September 7 /PRNewswire/ -- A third of patients have unnecessary tubes (cannulae) inserted when they are in hospital, needlessly exposing them to serious complications such as infection and...

Simple Test to Detect Fake Medicines
7th September 2008 LONDON, September 7 /PRNewswire/ -- The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is...

New Hope in Sight for Cataract Patients: Coated Lenses set to Reduce Post-Op Infection
7th September 2008 LONDON, September 7 /PRNewswire/ -- Research presented at the British Pharmaceutical Conference (BPC) in Manchester reveals that coating an artificial lens with antibiotics could significantly reduce...

Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008
6th September 2008 LONDON, September 6 /PRNewswire/ -- CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its...

Basil Holds the Key to Anti-Ageing
6th September 2008 LONDON, September 6 /PRNewswire/ -- Basil can protect against the harmful effects of ageing, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. Holy...

Benefits of Seasonal Flu Vaccination in the Workplace
5th September 2008 HITCHIN, England, September 5 /PRNewswire/ -- The 'Impact of Flu in the Workplace' conference is bringing together, for the first time, leading experts from occupational health, medicine and the NHS...

33rd ESMO Congress in Stockholm, 12-16 September 2008
5th September 2008 LUGANO, Switzerland, September 5 /PRNewswire/ -- The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal...

Migraine With Aura may be Linked to Increased Risk of Stroke and Heart Attacks and Must be Taken Seriously by GPs
5th September 2008 LONDON, September 5 /PRNewswire/ -- Doctors need to pay special attention to people with migraine with aura as they could be at increased risk of stroke or heart attack, a London conference heard...

Nventa to Present at Upcoming Investor Conferences
3rd September 2008 SAN DIEGO, September 3 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company will present corporate updates at a number of upcoming industry and financial...

Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
2nd September 2008 CARLSBAD, California, September 2 /PRNewswire/ -- Ablation Frontiers, Inc., announced today that two important studies, involving its innovative atrial fibrillation ablation products were...

ApoA-I Data Presented at European Society of Cardiology Congress
2nd September 2008 CALGARY, Canada, September 2 /PRNewswire/ -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Dr. Norman Wong presented key clinical data pertaining to its...

n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
2nd September 2008 MUNICH - ESC Congress 2008, September 2 /PRNewswire/ -- For the first time, results from a new landmark trial of purified n-3 polyunsaturated fatty acids (n-3 PUFAs) were presented at one of the...

Partnering consultation free of charge
Pharmalicensing Jobs
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us